PTEN and prostate carcinoma: In a mouse prostate cancer model driven by loss of Pten and Smad4, MDSCs play a critical role in cancer progression, as CXCR2-expressing MDSCs infiltrate in the prostate due to CXCL5 up-regulation in tumors [150].